Lifecore Biomedical annual meeting elects five directors, ratifies auditor, approves say-on-pay

LIFECORE BIOMEDICAL, INC. DE

Matthew Korenberg, Humberto Antunes, Nelson Obus, Katrina Houde elected by common and preferred holders voting together; Christopher Kiper elected solely by preferred holders.
Nelson Obus received 2,115,224 votes against, the highest among common stock directors; rest received fewer than 200,000 against.
Ratification of BDO USA as auditor for FY2025 passed with 31,279,291 for, 29,609 against, 38,781 abstain.
Advisory vote on executive compensation approved with 23,645,284 for, 163,003 against, 41,099 abstain; broker non-votes 7,498,295.
Total shares of common stock outstanding and entitled to vote at record date: 36,855,072; Series A Preferred on as-converted basis: 5,889,404.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.